Overcoming Formulation Challenges For mRNA Or High-Concentration Proteins

Source: Catalent

In recent years, the industry witnessed new demand for protein delivery and the emergence of advanced modalities, such as mRNA. However, their development is met with technical challenges, including high-concentration formulations, stability and degradation. To address those concerns, optimizing formulation components, including high-throughput analytics methods, automation, statistical approach, and excipient design can help. In this webinar, experts will discuss how to improve the formulation development of high-concentration mAbs for subcutaneous delivery to reduce viscosity, and potentially reduce costs and timelines, and how to overcome current challenges met in formulating mRNA lipid nanoparticles (mRNA-LNP).

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader